Evidence map›Paper›PMID 37173422›Full record

ReviewCellular & molecular immunology2023

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases.

Annu Devi, Isha Pahuja, Shashi Prakash Singh, Akanksha Verma, Debapriya Bhattacharya, Ashima Bhaskar, Ved Prakash Dwivedi, Gobardhan Das

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Drug resistance mechanisms inFrontiers in pharmacology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Mucosal-associated invariant T-cells in pulmonary pathophysiology.Current opinion in pulmonary medicine · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Annu Devi *Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Isha Pahuja *Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Shashi Prakash SinghSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Akanksha VermaImmunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Debapriya BhattacharyaCentre for Biotechnology, Siksha O Anusandhan University, Bhubneshwar, Odisha, India.
Ashima BhaskarImmunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Ved Prakash DwivediImmunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. dwivedived235@gmail.com.ORCID 0000-0003-4321-2567
Gobardhan DasSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India. gobardhan.das07@gmail.com.
International Centre for Genetic Engineering and Biotechnology · INJawaharlal Nehru University · INJamia Hamdard · INSiksha O Anusandhan University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) play diverse roles ranging from regeneration and wound healing to immune signaling. Recent investigations have indicated the crucial role of these multipotent stem cells in regulating various aspects of the immune system. MSCs express unique signaling molecules and secrete various soluble factors that play critical roles in modulating and shaping immune responses, and in some other cases, MSCs can also exert direct antimicrobial effects, thereby helping with the eradication of invading organisms. Recently, it has been demonstrated that MSCs are recruited at the periphery of the granuloma containing Mycobacterium tuberculosis and exert "Janus"-like functions by harboring pathogens and mediating host protective immune responses. This leads to the establishment of a dynamic balance between the host and the pathogen. MSCs function through various immunomodulatory factors such as nitric oxide (NO), IDO, and immunosuppressive cytokines. Recently, our group has shown that M.tb uses MSCs as a niche to evade host protective immune surveillance mechanisms and establish dormancy. MSCs also express a large number of ABC efflux pumps; therefore, dormant M.tb residing in MSCs are exposed to a suboptimal dose of drugs. Therefore, it is highly likely that drug resistance is coupled with dormancy and originates within MSCs. In this review, we discussed various immunomodulatory properties of MSCs, their interactions with important immune cells, and soluble factors. We also discussed the possible roles of MSCs in the outcome of multiple infections and in shaping the immune system, which may provide insight into therapeutic approaches using these cells in different infection models.

Indexed as

Communicable DiseasesMesenchymal Stem CellsMycobacterium tuberculosisTuberculosisCytokinesHumansImmunomodulationCytokinesImmunomodulationImmunotherapy.Infectious DiseasesMacrophagesMesenchymal Stem Cells (MSCs)T cellsTuberculosis

Identifiers

PMID37173422
PMCPMC10176304
OpenAlexW4376254691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.